Logo image of SLE

SUPER LEAGUE ENTERPRISE INC (SLE) Stock Fundamental Analysis

NASDAQ:SLE - Nasdaq - US86804F3010 - Common Stock - Currency: USD

4.19  -0.18 (-4.12%)

After market: 4.15 -0.04 (-0.95%)

Fundamental Rating

1

Overall SLE gets a fundamental rating of 1 out of 10. We evaluated SLE against 70 industry peers in the Interactive Media & Services industry. SLE has a bad profitability rating. Also its financial health evaluation is rather negative. SLE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

SLE had negative earnings in the past year.
In the past year SLE has reported a negative cash flow from operations.
SLE had negative earnings in each of the past 5 years.
SLE had a negative operating cash flow in each of the past 5 years.
SLE Yearly Net Income VS EBIT VS OCF VS FCFSLE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

SLE has a Return On Assets of -159.55%. This is amonst the worse of the industry: SLE underperforms 98.57% of its industry peers.
Industry RankSector Rank
ROA -159.55%
ROE N/A
ROIC N/A
ROA(3y)-181.55%
ROA(5y)-140.01%
ROE(3y)-3511.32%
ROE(5y)-2145.61%
ROIC(3y)N/A
ROIC(5y)N/A
SLE Yearly ROA, ROE, ROICSLE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

1.3 Margins

SLE has a worse Gross Margin (37.89%) than 77.14% of its industry peers.
SLE's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for SLE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.98%
GM growth 5Y-6.5%
SLE Yearly Profit, Operating, Gross MarginsSLE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

0

2. Health

2.1 Basic Checks

SLE does not have a ROIC to compare to the WACC, probably because it is not profitable.
SLE has more shares outstanding than it did 1 year ago.
SLE has more shares outstanding than it did 5 years ago.
The debt/assets ratio for SLE is higher compared to a year ago.
SLE Yearly Shares OutstandingSLE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
SLE Yearly Total Debt VS Total AssetsSLE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

SLE has an Altman-Z score of -39.47. This is a bad value and indicates that SLE is not financially healthy and even has some risk of bankruptcy.
SLE has a Altman-Z score of -39.47. This is amonst the worse of the industry: SLE underperforms 91.43% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -39.47
ROIC/WACCN/A
WACC8.84%
SLE Yearly LT Debt VS Equity VS FCFSLE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

SLE has a Current Ratio of 0.33. This is a bad value and indicates that SLE is not financially healthy enough and could expect problems in meeting its short term obligations.
SLE has a worse Current ratio (0.33) than 95.71% of its industry peers.
A Quick Ratio of 0.33 indicates that SLE may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.33, SLE is doing worse than 94.29% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.33
Quick Ratio 0.33
SLE Yearly Current Assets VS Current LiabilitesSLE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 73.54% over the past year.
Looking at the last year, SLE shows a very negative growth in Revenue. The Revenue has decreased by -43.43% in the last year.
SLE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 71.84% yearly.
EPS 1Y (TTM)73.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.68%
Revenue 1Y (TTM)-43.43%
Revenue growth 3Y11.51%
Revenue growth 5Y71.84%
Sales Q2Q%-35.42%

3.2 Future

Based on estimates for the next years, SLE will show a very strong growth in Earnings Per Share. The EPS will grow by 38.10% on average per year.
The Revenue is expected to grow by 3.96% on average over the next years.
EPS Next Y78.79%
EPS Next 2Y38.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-17.09%
Revenue Next 2Y3.96%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SLE Yearly Revenue VS EstimatesSLE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M 20M 25M
SLE Yearly EPS VS EstimatesSLE Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 -10 -20 -30

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

SLE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SLE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SLE Price Earnings VS Forward Price EarningsSLE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SLE Per share dataSLE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1 -1.5

4.3 Compensation for Growth

SLE's earnings are expected to grow with 38.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.1%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SLE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SUPER LEAGUE ENTERPRISE INC

NASDAQ:SLE (6/24/2025, 7:59:24 PM)

After market: 4.15 -0.04 (-0.95%)

4.19

-0.18 (-4.12%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)05-15 2025-05-15/amc
Earnings (Next)08-12 2025-08-12
Inst Owners1.27%
Inst Owner Change21.49%
Ins Owners0.95%
Ins Owner Change0%
Market Cap101.31M
Analysts80
Price TargetN/A
Short Float %6.58%
Short Ratio0.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-23.19%
Min EPS beat(2)-71.36%
Max EPS beat(2)24.99%
EPS beat(4)2
Avg EPS beat(4)-12.01%
Min EPS beat(4)-71.36%
Max EPS beat(4)24.99%
EPS beat(8)5
Avg EPS beat(8)-0.67%
EPS beat(12)9
Avg EPS beat(12)7.9%
EPS beat(16)12
Avg EPS beat(16)9.38%
Revenue beat(2)0
Avg Revenue beat(2)-21.96%
Min Revenue beat(2)-38.33%
Max Revenue beat(2)-5.59%
Revenue beat(4)0
Avg Revenue beat(4)-26.48%
Min Revenue beat(4)-38.33%
Max Revenue beat(4)-5.59%
Revenue beat(8)2
Avg Revenue beat(8)-12.4%
Revenue beat(12)2
Avg Revenue beat(12)-12.42%
Revenue beat(16)5
Avg Revenue beat(16)-6.86%
PT rev (1m)-45.45%
PT rev (3m)-66.67%
EPS NQ rev (1m)11.36%
EPS NQ rev (3m)-21.87%
EPS NY rev (1m)21.64%
EPS NY rev (3m)-28.05%
Revenue NQ rev (1m)-20.62%
Revenue NQ rev (3m)-48.26%
Revenue NY rev (1m)-4.54%
Revenue NY rev (3m)-38.83%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.9
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.63
EYN/A
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)-0.43
FCFYN/A
OCF(TTM)-0.41
OCFYN/A
SpS0.61
BVpS-0.14
TBVpS-0.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -159.55%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 37.89%
FCFM N/A
ROA(3y)-181.55%
ROA(5y)-140.01%
ROE(3y)-3511.32%
ROE(5y)-2145.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.98%
GM growth 5Y-6.5%
F-Score3
Asset Turnover1.5
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18.1%
Cap/Sales 3.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.33
Quick Ratio 0.33
Altman-Z -39.47
F-Score3
WACC8.84%
ROIC/WACCN/A
Cap/Depr(3y)20.68%
Cap/Depr(5y)37.55%
Cap/Sales(3y)4.74%
Cap/Sales(5y)16.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.68%
EPS Next Y78.79%
EPS Next 2Y38.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-43.43%
Revenue growth 3Y11.51%
Revenue growth 5Y71.84%
Sales Q2Q%-35.42%
Revenue Next Year-17.09%
Revenue Next 2Y3.96%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y19.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year40.62%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y42.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y39.92%
OCF growth 3YN/A
OCF growth 5YN/A